Intellectual property issues can be critical at the time a startup is considering a sale. In this video, partner Tim Harris explains several reasons why an acquirer will scrutinize a startup’s intellectual property before moving forward with a purchase.
Careful IP planning is especially important in the life sciences, in which companies often rely on only a handful of patents to protect a high-market value product such as an FDA-approved drug. In this article, MoFo counsel Lisa Silverman details the importance of patent protection for life sciences companies, highlighting the long-term benefits of patent term extension and how to identify which assets to prioritize. Originally appearing in the Daily Journal, read the article here.
Investor due diligence into a startup’s foundational intellectual property and make or break a potential investment. In this video, partner Tim Harris describes IP-related pitfalls that discourage investors from backing a startup.
Your startup has a name. Now what? This article describes how your company should navigate common trademark issues.
MoFo partner Tim Harris describes three common intellectual property mistakes that startups make involving securing intellectual property titles, intention agreements, and proper licensing. Watch this video to learn more.
A string of Supreme Court of the United States rulings demonstrate a lack of patent protection for biotech inventions, and SCOTUS efforts to explain its long-held exceptions to Section 101 – laws of nature, physical phenomena, and abstract ideas – have created greater confusion and an increased number of ineligible patents. This article argues that a legislative fix may be the best remedy to the biotech patent issue.
In this short video, MoFo partner Tim Harris explains the many ways intellectual property can add value to a startup. Watch this video to learn more.
IP due diligence allows investors to accurately assess the value of the underlying IP and associated risks. This article describes what is considered in life sciences deals. Read the full article.